# TAI Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tai-diagnostics

- Industry: Biotechnology
- Headquarters: Milwaukee, US
- Website: https://taidiagnostics.com/
- Total disclosed funding: $8.2M
- Latest round: Series A (Oct 23, 2015)
- Investors on record: 1

## About

TAI Diagnostics, Inc. is a company specializing in premium domain names for the diagnostics sector, providing essential digital assets to enhance the online presence of healthcare businesses and professionals.Founded in 2015 and headquartered in Milwaukee, US, TAI Diagnostics, Inc. focuses on offering domain names to companies in the diagnostics field. The company has completed 4 deals, with its most recent financing round being a Series A round in January 2018, which raised USD 10 mn. The founder's previous ventures are not publicly detailed, and no information is available on subsidiaries or parent companies.TAI Diagnostics, Inc. primarily offers a premium domain name for sale that targets businesses and individuals keen on establishing a strong online presence within the diagnostics sector. The domain name functions as a digital asset and branding tool, enhancing recognition and trust among clients in the healthcare industry. Its market includes startups, established healthcare companies, and diagnostic laboratories across regions such as the United States, Western Europe, and parts of Asia. The domain is available for immediate access upon purchase through a user-friendly online platform.TAI Diagnostics, Inc. generates revenue directly through the sale of its domain name, listed at a price of USD 14,695, with a payment plan option of USD 612.29 monthly for 24 months without interest. This pricing structure appeals to both individual entrepreneurs and corporate clients, allowing transactions to occur directly through its website in a B2B model. Revenue is bolstered by a satisfaction guarantee, along with potential upselling opportunities like WhoIs Privacy Protection services for domain owners.Following the Series A financing round in January 2018, in which TAI Diagnostics, Inc. raised USD 10 mn, the company aims to expand its product offerings and target new geographic markets. The specifics of upcoming products or their launch dates have not been disclosed. The company's future plans include exploring regions with increasing healthcare digitalization interests, although specific targets have yet to be outlined.

## Funding rounds

- Series A, Oct 23, 2015, $8.2M — Venture Investors

## Investors

- Venture Investors — Series A